Obalon Therapeutics

Obalon Therapeutics

Obalon Therapeutics

Obalon Therapeutics offers gastric balloon technology that assists weight lossby inducing a feeling of fullness.
Founded
2008
Raised
$95.9M
Follow us
Alexa global traffic share
Latest funding Show all
$75,000,000
Post-IPO equity - 2016
$15,899,998
Venture capital - 2014
Team Size
50+
Employees
$75,000,000 Post-IPO equity
San Diego Business Journal , The San Diego Union-Tribune

Obalon Therapeutics Announces $75M IPO; Gets FDA Approval

Health